Company
Tolerance Bio
Tolerance Bio will increase health span by preserving, restoring, and manipulating the function of the thymus, the master regulator of immune tolerance
- Legal name
- Tolerance Bio, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Tolerance Bio will increase health span by preserving, restoring, and manipulating the function of the thymus, the master regulator of immune tolerance
Funding snapshot
- Total raised
- $15.1MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $15.1M2026-06-03
Funding rounds
- Round, 2026
- $15.1M2026-06-03, SEC form D sold, 13 investors
Products
- Web
- Efineptakin Alfa
- Web
- iPSC-derived Thymic Organoids
Loading relationship preview